Investor Presentation First Nine Months of 2023
24.
Investor presentation
First nine months of 2023
Sales growth of 33%, driven by both NAO and IO with 49% and
17% sales growth respectively
Total in
DKK billion
Historic and reported sales by geography
Reported sales and growth breakdown
for the first nine months of 2023
Novo NordiskⓇ
111.8
177.0
166.4
Regions
Sales
(mDKK)
Share of
Growth
growth
9%
14%
13%
10%
International Operations
72,390
17%
26%
9%
8%
EMEA
38,161
19%
15%
30%
23%
25%
Region China
13,269
12%
4%
ROW
20,960
16%
7%
North America Operations
94,008
49%
74%
56%
51%
52%
Hereof USA
87,467
49%
69%
Total sales
166,398
33%
100%
2018
2022
9M 2023
North America
EMEA
Region China
ROW
Source: Quarterly company announcement
IO: International Operations; NAO: North American Operations; EMEA: Europe, Middle East, and Africa; Row: Rest of World; Region China covers mainland China, Hong Kong and Taiwan; 9M: 9 months
Note: Numbers may not add up to 100% due to rounding; Growth at Constant exchange rates; Sales numbers are reported in Danish kronerView entire presentation